Literature DB >> 98829

Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids.

C E Mogensen.   

Abstract

Urinary excretion of albumin, free light chains of immunoglobulins and beta-2-microglobulin was measured after injection of certain amino acids and derivatives. Substances with a positively charged group located terminally in the molecule (ornithine, lysine, arginine, and the almost not metabolized epsilon-amino-caproic acid, and Cyclocaprone) proved to inhibit instantaneously the tubular protein reabsorption. Lysine is the most effective molecule tested. We hypothesize that the initial event in the normal tubular protein reabsorption is a binding between a free positive amino- or guanidino-group in the protein molecule and a negative site on the tubular cell surface. In an attempt to achieve complete inhibition of tubular protein reabsorption, large doses of lysine were injected intravenously. The maximal protein clearance rose from the exceedingly low baseline excretion to values probably representing near complete inhibition of protein reabsorption. The minimal value of albumin concentration in the glomerular filtrate was calculated to 2.6 mg/l.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 98829     DOI: 10.3109/00365517709101835

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  39 in total

1.  68Ga-DOTA-GGNle-CycMSHhex targets the melanocortin-1 receptor for melanoma imaging.

Authors:  Jianquan Yang; Jingli Xu; Rene Gonzalez; Thomas Lindner; Clemens Kratochwil; Yubin Miao
Journal:  Sci Transl Med       Date:  2018-11-07       Impact factor: 17.956

2.  Urinary excretion of albumin and transferrin in lithium maintenance treatment: daily versus alternate-day lithium dosing schedule.

Authors:  H V Jensen; J Holm; K Davidsen; L Toftegaard; H Aggernaes; N Bjørum
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

Review 3.  Impact of physiochemical properties on pharmacokinetics of protein therapeutics.

Authors:  Rajan Swami; Aliasgar Shahiwala
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-04-14       Impact factor: 2.441

4.  In vivo bacteriophage peptide display to tailor pharmacokinetics of biological nanoparticles.

Authors:  Jessica R Newton-Northup; Marie T Dickerson; Senthil R Kumar; George P Smith; Thomas P Quinn; Susan L Deutscher
Journal:  Mol Imaging Biol       Date:  2014-12       Impact factor: 3.488

5.  The origin of proteinuria at high altitude.

Authors:  M H Winterborn; A R Bradwell; I M Chesner; G T Jones
Journal:  Postgrad Med J       Date:  1987-03       Impact factor: 2.401

6.  Protection of Cystinotic Mice by Kidney-Specific Megalin Ablation Supports an Endocytosis-Based Mechanism for Nephropathic Cystinosis Progression.

Authors:  Virginie Janssens; Héloïse P Gaide Chevronnay; Sandrine Marie; Marie-Françoise Vincent; Patrick Van Der Smissen; Nathalie Nevo; Seppo Vainio; Rikke Nielsen; Erik I Christensen; François Jouret; Corinne Antignac; Christophe E Pierreux; Pierre J Courtoy
Journal:  J Am Soc Nephrol       Date:  2019-09-23       Impact factor: 10.121

7.  Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice.

Authors:  Ann-Charlott Steffen; Anna Orlova; Maria Wikman; Fredrik Y Nilsson; Stefan Ståhl; Gregory P Adams; Vladimir Tolmachev; Jörgen Carlsson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-15       Impact factor: 9.236

8.  The effect of prostaglandin E1 during cardiopulmonary bypass on renal function after cardiac surgery.

Authors:  K Abe; Y Fujino; T Sakakibara
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Glomerular size- and charge selectivity in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.

Authors:  M A Gall; P Rossing; A Kofoed-Enevoldsen; F S Nielsen; H H Parving
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

10.  Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides.

Authors:  Erik Vegt; Annemarie Eek; Wim J G Oyen; Marion de Jong; Martin Gotthardt; Otto C Boerman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-01       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.